How Muscarinic Modulators May Shape Schizophrenia Treatment, with Jonathan Meyer, MD

Описание: In this interview, Jonathan Meyer, MD, a clinical professor from the University of California, San Diego, shares his expert insights on the role of muscarinic modulators in schizophrenia treatment. Following his presentation at the 2024 Southern California Psychiatry Conference, Meyer discusses the neurobiological findings that xanomeline trospium chloride capsules (Copenfy) has brought to light, particularly in reducing positive symptoms of schizophrenia without d2 receptor-related adverse events.

Meyer also highlights the cognitive benefits observed in some patients, as well as the medication's safety profile and unique warnings, such as urinary retention and constipation. Discover how this novel treatment marks a significant shift in managing schizophrenia symptoms.

Key Timestamps:

00:07: How Muscarinic Modulators Enhance Our Understanding of Schizophrenia's Neurobiology
00:53: Promising Outcomes with Muscarinic Modulators
04:35: Clinicians Role in In Ensuring Muscarinic Modulator's Safe and Effective Use
05:47: Xanomeline Trospium Chloride Capsules' Potential Influence on the Paradigm Schizophrenia Treatment

Read the full article on HCPLive: https://www.hcplive.com/view/jonathan...

#Schizophrenia #XanomelineTrospium #MuscarinicModulators #Psychiatry #MentalHealth #Copenfy #KarXT #SchizophreniaTreatment